WAY

Waystar Holding Corp

Add to Watchlist

Advanced Chart

34.590

+0.68(2.005%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

34.620

Open

33.910

VWAP

34.23

Vol

1.57M

Mkt Cap

6.03B

Low

33.500

Amount

53.81M

EV/EBITDA(TTM)

18.45

Total Shares

174.24M

6.93B

EV/OCF(TTM)

22.74

P/S(TTM)

6.08

Waystar Holding Corp. provides healthcare organizations with mission-critical cloud software that simplifies healthcare payments. The Company’s enterprise-grade platform, Waystar, streamlines the complex processes. It leverages internally developed artificial intelligence (AI) as well as proprietary, advanced algorithms to automate payment-related workflow tasks and drive continuous improvement, which enhances claim and billing accuracy, enriches data integrity, and reduces labor costs for providers. Its software is used daily by providers of all types and sizes across the continuum of care, including physician practices, clinics, surgical centers, and laboratories, as well as large hospitals and health systems. The Company’s clients utilize its software to manage pre-encounter workflows, such as eligibility checks and prior authorization approvals, as well as mid- and post-encounter workflows, such as co-pay collection, claims submission and monitoring, and payer remittances.

11 Analyst Rating

43.91% Upside

Wall Street analysts forecast WAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WAY is 49.78 USD with a low forecast of 45.00 USD and a high forecast of 54.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

11 Buy

0 Hold

0 Sell

Strong Buy

43.91% Upside

Current: 34.590

Low

45.00

Averages

49.78

High

54.00

43.91% Upside

Current: 34.590

Low

45.00

Averages

49.78

High

54.00

Deutsche Bank

Buy

maintain

$45 -> $50

2025-08-01

Reason

Deutsche Bank

Price Target

$45 -> $50

2025-08-01

maintain

Buy

Reason

Deutsche Bank raised the firm's price target on Waystar to $50 from $45 and keeps a Buy rating on the shares. The company reported a beat and spoke of artificial intelligence, the analyst tells investors in a research note. The firm believes Waystar's guidance could prove conservative.

Truist

Buy

maintain

$50 -> $51

2025-07-17

Reason

Truist

Price Target

$50 -> $51

2025-07-17

maintain

Buy

Reason

Truist raised the firm's price target on Waystar to $51 from $50 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 results for Health Care IT / Digital Health sector names. Despite the strong YTD outperformance in shares, investor sentiment still remains relatively mixed, with the interest level from long-onlies/generalist investors seen as "relatively selective", the analyst tells investors in a research note. HCIT space has also benefited from the lack of direct tariff exposure and other macro uncertainty as well as renewed capital market activity, the firm added.

Mizuho

Steven Valiquette

Outperform

initiated

$48

2025-06-30

Reason

Mizuho

Steven Valiquette

Price Target

$48

2025-06-30

initiated

Outperform

Reason

Mizuho analyst Steven Valiquette initiated coverage of Waystar with an Outperform rating and $48 price target. Shares outperformed in 2024 as the company benefited from a Q1 cyberattack on a primary competitor and the associated market share gains translated into 19% revenue growth last year, though the stock has performed "more modestly" in 2025, partly due to initial 2025 "reported" revenue growth guidance below long-term targets given revenue pull-forward last year, the analyst tells investors. Based on channel checks, the firm expects Waystar to maintain market share beyond this and capitalize on selling newer AI-driven solutions into the installed base, the analyst added.

Citi

NULL -> Buy

initiated

$45

2025-06-25

Reason

Citi

Price Target

$45

2025-06-25

initiated

NULL -> Buy

Reason

Citi initiated coverage of Waystar with a Buy rating and $45 price target. The company has built "an impressive suite" of cloud-based revenue cycle management solutions and is set to capitalize on the "often-touted (but rarely realized) AI boon in healthcare," the analyst tells investors in a research note. The firm thinks artificial intelligence use cases to streamline admin processes is real and accelerating and that revenue cycle management "presents the most propitious opportunity." Within the modular landscape, Citi favors Waystar, saying it has the most comprehensive suite of solutions.

TD Cowen

Charles Rhyee

Buy

initiated

$51

2025-06-05

Reason

TD Cowen

Charles Rhyee

Price Target

$51

2025-06-05

initiated

Buy

Reason

TD Cowen analyst Charles Rhyee initiated coverage of Waystar with a Buy rating and $51 price target. Waystar is a leading provider of software-as-a-service products for healthcare providers, including patient payments and clearinghouse solutions, the analyst tells investors in a research note. The firm believes the company should benefit from favorable underlying fundamentals, including complex billing processes and rising out-of-pocket patient costs.

Barclays

Stephanie Davis

Buy

Maintains

$50 → $45

2025-04-14

Reason

Barclays

Stephanie Davis

Price Target

$50 → $45

2025-04-14

Maintains

Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Waystar Holding Corp (WAY.O) is 23.80, compared to its 5-year average forward P/E of 38.04. For a more detailed relative valuation and DCF analysis to assess Waystar Holding Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

38.04

Current PE

23.80

Overvalued PE

47.57

Undervalued PE

28.52

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

17.63

Current EV/EBITDA

16.11

Overvalued EV/EBITDA

19.37

Undervalued EV/EBITDA

15.89

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

5.67

Current PS

5.56

Overvalued PS

6.73

Undervalued PS

4.62